Skip Navigation
Find a Doctor


Search for
other physicians or researchers.

Find a Doctor
Photo of Dr. Robert Francis Siliciano, MD PhD

Robert Francis Siliciano, MD PhD

Joint Appointment in Molecular Biology and Genetics
Professor of Medicine


  • Joint Appointment in Molecular Biology and Genetics
  • Professor of Medicine
  • Joint of Molecular Biology and Genetics
  • Professor of Pharmacology and Molecular Sciences


Dr. Robert Siliciano is a Professor of Medicine in the Infectious Diseases Department. He studies HIV, specifically viral reservoirs that prevent curing HIV infection and trying to better understand how the T-cell reservoir is established and maintained.

Dr. Siliciano holds a bachelor’s degree from Princeton University and medical degree and PhD from Johns Hopkins. He completed a postdoctoral fellowship at Harvard Medical School before joining the Johns Hopkins faculty. Dr. Siliciano is an investigator in the Howard Hughes Medical Institute, and his work has been recognized by a Distinguished Clinical Scientist Award from the Doris Duke Charitable Foundation and two merit awards from the National Institutes of Health. 


  • English
Additional Resources +
  • Education +
  • Research & Publications +

    Selected Publications

    Amy F Weil; Devlina Ghosh; Yan Zhou; Lauren Seiple; Moira A McMahon; Adam M Spivak; Robert F Siliciano; James T Stivers. Uracil DNA glycosylase initiates degradation of HIV-1 cDNA containing misincorporated dUTP and prevents viral integration. Proceedings of the National Academy of Sciences of the United States of America 2013;110(6):E448-57.
    View on Pubmed

    Susanne Eriksson; Erin H Graf; Viktor Dahl; Matthew C Strain; Steven A Yukl; Elena S Lysenko; Ronald J Bosch; Jun Lai; Stanley Chioma; Fatemeh Emad; et al. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS pathogens 2013;9(2):e1003174.
    View on Pubmed

    Daniela Boehm; Vincenzo Calvanese; Roy D Dar; Sifei Xing; Sebastian Schroeder; Laura Martins; Katherine Aull; Pao-Chen Li; Vicente Planelles; James E Bradner; et al. BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism. Cell cycle (Georgetown, Tex.) 2013;12(3):452-62.
    View on Pubmed

  • Academic Affiliations & Courses +
  • Activities & Honors +
  • Videos & Media +
  • Upcoming Events +
  • Contact & Locations +


    • Medicine - Infectious Diseases
    • Molecular Biology and Genetics
    • Pharmacology and Molecular Sciences

Is This You? Edit Profile


© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer